By Kathrin Folkendt Biotech, Chronic Conditions, News, Partnership January 18, 2022 ShareTwitterFacebookPinterest-circled Celmatix, Evotec & Bayer Just Hit Another Milestone in Their Quest to Develop a First-in-Class Drug for PCOS
